Kristina Isakovich

Kristina is the Global Co-Leader of the Transformation Practice Group and a Partner & Managing Director at AlixPartners. With over 20 years of experience driving transformational change, Kristina is renowned for her ability to navigate complex business challenges across diverse industries, including healthcare, life sciences, and high technology. 

Throughout her career, Kristina has demonstrated an aptitude for developing and implementing strategic solutions that address intricate business problems. Her multi-functional expertise spans corporate and product strategy, strategic marketing, customer insights, product development, pricing, and operational performance improvement. She is also well-versed in growth strategies, market entry strategies, and building and leading high-performing teams. 

Prior to joining AlixPartners, Kristina held senior roles as Chief Marketing Officer and Chief Strategy Officer at Fortune 500 companies. Her leadership in these positions included managing global marketing organizations, driving product strategy and go-to-market efforts for medical devices and life sciences tools.  She has also overseen cost-reduction, operational improvement and post-merger integration initiatives in aerospace, healthcare and other sectors.   

Kristina has also served as an Advisor and Board Director for several companies, notably guiding Epsilon Imaging on strategy, marketing, and product positioning, as well as advising Wellist on marketing and user experience. 

Key Engagements and Career Highlights: 

• Developed and implemented marketing transformations for global life sciences companies, enhancing market assessments, customer segmentation, solutions selling, business case development, and account targeting.
• Led operating model redesign and functional rationalization for large global companies, improving operational effectiveness and enabling efficient scaling of support functions.
• Led optimization of corporate and shared service functions, applying “lean corporate” principles to achieve 25+% reductions in company-wide G&A costs.
• Led large-scale post-merger integration efforts across multiple companies, ensuring seamless transitions and operational efficiency.
• Led operating model redesign and process improvements for multiple networks of ambulatory healthcare centers, enabling more efficient support operations, higher patient throughput and increased staff capacity.
• Crafted business and market entry strategies for aerospace, healthcare, and communications companies.
• Designed and implemented strategic pricing programs, leading to $200 million in increased annual operating profits.
• Advised CEOs and boards of directors on improving market capitalization through business restructuring.